e-learning
resources
ERJ
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The effect of smoking on exacerbation risk in eosinophilic patients with COPD
Christian R. Osadnik, Martin I. MacDonald, Philip G. Bardin
Source:
Eur Respir J, 50 (6) 1701820; 10.1183/13993003.01820-2017
Journal Issue:
December
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Christian R. Osadnik, Martin I. MacDonald, Philip G. Bardin. The effect of smoking on exacerbation risk in eosinophilic patients with COPD. Eur Respir J, 50 (6) 1701820; 10.1183/13993003.01820-2017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Lack of effect of acute exacerbations on disease progression in ex-smoker COPD patients
Source: Annual Congress 2010 - Distortions of the respiratory system in the lung function
Year: 2010
COPD patients with asthma, characteristics and risk of exacerbations
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
The influence of smoking on hydrolipoperoxidation in COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 306s
Year: 2003
Systemic interleukin-26 relates to the risk of exacerbations in smokers with COPD and chronic bronchitis
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
Smoking and concomitant medication as risk factors for exacerbation of bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 45s
Year: 2005
The tobacco smoking influence on parodontic inflammation in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 167s
Year: 2007
The risk of hyperkalemia in COPD and asthma patients
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019
Quantification of smokers and smoking status among COPD patients, hospitalized for an exacerbation
Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions?
Year: 2011
Physical activity practice reduces risk of admission for a COPD exacerbation in COPD from a prospective population based study
Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Year: 2005
An observational study of risk factors for hospitalization of chronic obstructive pulmonary disease exacerbation and their outcome
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Tobacco smoking habits by patients with chronic obstructive pulmonary disease (COPD) and their impact on number of hospitalizations
Source: Eur Respir J 2007; 30: Suppl. 51, 169s
Year: 2007
The impact of smoking cessation on respiratory symptoms in patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 391s
Year: 2005
The effect of tiotropium/olodaterol versus tiotropium on COPD exacerbation rates in patients with/without frequent exacerbation history
Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases
Year: 2019
The impact of airway infection on cardiovascular risk during COPD exacerbations
Source: Annual Congress 2012 - Acute exacerbation in COPD
Year: 2012
Detection of spirometrically-defined COPD in a population of smokers referred to a smoking cessation clinic
Source: Annual Congress 2006 - New investigational approaches to smoking and smoking cessation
Year: 2006
Coexisting cardiovascular diseases increase the risk of exacerbations in patients with COPD
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011
Increasing risk of exacerbation and mortality associated with increasing frequency and severity of exacerbations in COPD patients: EXACOS-UK
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
The positive effect of cilomilast on lung function in patients with chronic obstructive pulmonary disease (COPD) is independent of patient smoking status
Source: Eur Respir J 2002; 20: Suppl. 38, 620s
Year: 2002
COPD patients‘ response to smoking cessation
Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept